Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice
Authors:
- Rajeshwar Rao TekmalRTRajeshwar Rao Tekmal
- Ya-Guang LiuYLYa-Guang Liu
- Hareesh B. NairHNHareesh B. Nair
- Jeremy JonesJJJeremy Jones
- Rao P. PerlaRPRao P. Perla
- Dennis B. LubahnDLDennis B. Lubahn
- Kenneth S. KorachKKKenneth S. Korach
- Nameer KirmaNKNameer Kirma
- 1 May 2005
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 95 (1-5) , 9-15
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Phase III Study of Letrozole Versus Tamoxifen As First-Line Therapy of Advanced Breast Cancer in Postmenopausal Women: Analysis of Survival and Update of Efficacy From the International Letrozole Breast Cancer GroupJournal of Clinical Oncology, 2004
- Aromatase overexpression transgenic mice model: cell type specific expression and use of letrozole to abrogate mammary hyperplasia without affecting normal physiologyThe Journal of Steroid Biochemistry and Molecular Biology, 2001
- The effects of aromatase overexpression on mammary growth and gene expression in the aromatase x transforming growth factor alpha double transgenic miceThe Journal of Steroid Biochemistry and Molecular Biology, 2001
- Acceleration of mammary neoplasia in aromatase transgenic mice by 7,12-dimethylbenz[a]anthraceneCancer Letters, 2001
- Estrogen receptor β in the breast: role in estrogen responsiveness and development of breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2000
- Chapter 5: Tissue-Specific Synthesis and Oxidative Metabolism of EstrogensJNCI Monographs, 2000
- Overexpression of Aromatase Leads to Development of Testicular Leydig Cell TumorsThe American Journal of Pathology, 2000
- Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands.Endocrine-Related Cancer, 1999
- Generation and reproductive phenotypes of mice lacking estrogen receptor βProceedings of the National Academy of Sciences, 1998
- Aromatase activity in breast tissueThe Journal of Steroid Biochemistry and Molecular Biology, 1991